About Glycotest
Glycotest is a company based in New York (United States) founded in 2012. Glycotest has raised $7 million across 3 funding rounds from investors including Fosun Pharmaceutical. Glycotest offers products and services including Glycotest Blood Tests. Glycotest operates in a competitive market with competitors including EchoSens, Fibronostics, Inner Mongolia Furui Medical Science, Bilhi Genetics and Wuxi Hisky Medical, among others.
- Headquarter New York, United States
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
- Legal Name Glycotest, Inc
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$7 M (USD)
in 3 rounds
-
Latest Funding Round
$1 M (USD), Series A
Jan 23, 2024
- Investors
-
Employee Count
Not available
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Glycotest
Glycotest offers a comprehensive portfolio of products and services, including Glycotest Blood Tests.
Blood tests for early detection of liver cancers and fibrosis.
People of Glycotest
Unlock access to complete
Unlock access to complete
Funding Insights of Glycotest
Glycotest has successfully raised a total of $7M across 3 strategic funding rounds. The most recent funding activity was a Series A round of $1 million completed in January 2024. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in Glycotest
Glycotest has secured backing from 1 investor, including institutional investors. Prominent investors backing the company include Fosun Pharmaceutical.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Research, development, production, and sale of pharmaceuticals are provided.
|
Locked | Locked | Locked |
Investor details for Glycotest
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Glycotest
Investment portfolio details for Glycotest
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Glycotest
Detailed financials for Glycotest
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Glycotest Comparisons
Peer comparison for Glycotest
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Glycotest
Glycotest operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as EchoSens, Fibronostics, Inner Mongolia Furui Medical Science, Bilhi Genetics and Wuxi Hisky Medical, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Non-invasive diagnostics for liver disease detection are developed.
|
|
| Locked | Locked | Locked |
Non-invasive algorithm-based diagnostics
|
|
| Locked | Locked | Locked |
Therapeutic and diagnostic solutions for liver diseases are provided.
|
|
| Locked | Locked | Locked |
Genetic markers are utilized for disease prediction algorithms.
|
|
| Locked | Locked | Locked |
Non-invasive liver diagnosis systems are manufactured using TE technology.
|
Detailed competitors of Glycotest
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Glycotest
Complete news archive for Glycotest
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Glycotest
Glycotest was founded in 2012 and raised its 1st funding round 6 years after it was founded.
Glycotest is headquartered in New York, United States. It is registered at New York, New York, United States.
Larry Cohen is the current CEO of Glycotest.
Glycotest is a funded company, having raised a total of $7M across 3 funding rounds to date.
Glycotest was founded in 2012 and is headquartered in New York, United States. Operations focus on the diagnostics sector, where non-invasive blood tests are developed to detect liver cancers and fibrosis-cirrhosis. The technology measures abnormal levels of the monosaccharide fucose on serum glycoproteins to identify disease causes. Leadership is provided by CEO Larry Cohen, with activities centered on advancing these diagnostic tools.
Glycotest's top competitors include EchoSens, Inner Mongolia Furui Medical Science and Fibronostics.
Glycotest offers Glycotest Blood Tests.
Glycotest has 1 investor. Key investors include Fosun Pharmaceutical.